LON:VRCI Verici Dx Share Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Verici Dx plc Please log in to your account or sign up in order to add this asset to your watchlist. GBX 22 -1.92 (-8.03%) (As of 06/28/2022 09:00 PM ET) Add Compare Share Today's Range 20▼ 2450-Day Range 15▼ 30.4052-Week Range 14▼ 79.50Volume387,718 shsAverage Volume159,152 shsMarket Capitalization£37.47 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsHeadlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive VRCI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Verici Dx and its competitors with MarketBeat's FREE daily newsletter. Email Address VRCI Stock Forecast (MarketRank)Overall MarketRank™0.00 out of 5 starsAnalyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 - 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Verici Dx. Previous Next 0.0 Community Rank Outperform VotesVerici Dx has received 0 “outperform” votes. (Add your “outperform” vote.)Underperform VotesVerici Dx has received 0 “underperform” votes. (Add your “underperform” vote.)MarketBeat's community ratings are surveys of what our community members think about Verici Dx and other stocks. Vote “Outperform” if you believe VRCI will outperform the S&P 500 over the long term. Vote “Underperform” if you believe VRCI will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldVerici Dx does not currently pay a dividend.Dividend GrowthVerici Dx does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Verici Dx insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Verici Dx is -4.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Verici Dx is -4.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioVerici Dx has a P/B Ratio of 2.36. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Verici DxVerici Dx plc engages in developing and commercializing clinical diagnostics kidney transplant tests. The company was incorporated in 2020 and is based in Penarth, United Kingdom. As of July 10, 2020, Verici Dx plc is a former subsidiary of Renalytix AI plc.Read More VRCI Stock News HeadlinesJune 14, 2022 | marketwatch.comVerici Releases Data on Tuteva Blood Test; Shares DiveMay 5, 2022 | finance.yahoo.comAmerican Shared Hospital Services Announces First Quarter 2022 Earnings Conference CallApril 9, 2022 | lse.co.ukVerici Dx Share ChatMarch 26, 2022 | investing.comVerici Dx Plc (VRCI)See More Headlines Industry, Sector and Symbol Stock ExchangeLON Industry Diagnostics & Research Sub-IndustryN/A SectorMedical Current SymbolLON:VRCI CUSIPN/A CIKN/A Webwww.vericidx.com Phone44 207 9338780FaxN/AEmployees10Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio2,309.09 Current Ratio6.10 Quick Ratio5.87 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowGBX 6.68 per share Price / Cash Flow3.29 Book ValueGBX 8.50 per share Price / Book2.59Miscellaneous Outstanding Shares170,319,000Free FloatN/AMarket Cap£37.47 million OptionableNot Optionable BetaN/A Verici Dx Frequently Asked Questions How has Verici Dx's stock performed in 2022? Verici Dx's stock was trading at GBX 53 at the beginning of 2022. Since then, VRCI shares have decreased by 58.5% and is now trading at GBX 22. View the best growth stocks for 2022 here. Who are Verici Dx's key executives? Verici Dx's management team includes the following people: Ms. Sara Barrington A.C.A., A.C.I.M., CEO & Exec. Director (Age 54, Pay $415.78k)Mr. Salim Hamir F.C.A., Company Sec. Who are some of Verici Dx's key competitors? Some companies that are related to Verici Dx include Renalytix (RENX), Profound Medical (PRN), Akumin (AKU), SQI Diagnostics (SQD), Oncimmune (ONC), Yourgene Health (YGEN), VentriPoint Diagnostics (VPT), Cambridge Cognition (COG), GeneNews (GEN), LexaGene (LXG), GENinCode (GENI), genedrive (GDR), LED Medical Diagnostics (LMD), Abingdon Health (ABDX) and Integrated Diagnostics (IDHC). View all of VRCI's competitors. What is Verici Dx's stock symbol? Verici Dx trades on the London Stock Exchange (LON) under the ticker symbol "VRCI." How do I buy shares of Verici Dx? Shares of VRCI and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is Verici Dx's stock price today? One share of VRCI stock can currently be purchased for approximately GBX 22. How much money does Verici Dx make? Verici Dx (LON:VRCI) has a market capitalization of £37.47 million. How many employees does Verici Dx have? Verici Dx employs 10 workers across the globe. How can I contact Verici Dx? The official website for Verici Dx is www.vericidx.com. The company can be reached via phone at 44 207 9338780. This page (LON:VRCI) was last updated on 6/29/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here
